Finance

Lists
Why is BALAXI up १४.८८%?
Dive Deeper
BALAXI:NSE
Balaxi Pharmaceuticals Ltd
₹ ३०.४१
+१४.८८%
(+३.९४) 1D
नोभेम्बर १८, ११:३७:३० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BALAXI...
Open
₹ ३०.००
High
₹ ३०.९०
Low
₹ २७.८०
Mkt. cap
१.६६ अरब
Avg. vol.
२९.७१ हजार
Volume
६.२६ लाख
P/E ratio
६८.७८
52-wk high
₹ ४०.९८
52-wk low
₹ १५.२०
EPS
₹ ०.४४
No. of employees
५००
Open
₹ ३०.००
High
₹ ३०.९०
Low
₹ २७.८०
Mkt. cap
१.६६ अरब
Avg. vol.
२९.७१ हजार
Volume
६.२६ लाख
P/E ratio
६८.७८
52-wk high
₹ ४०.९८
52-wk low
₹ १५.२०
EPS
₹ ०.४४
No. of employees
५००
News stories
From web sources and news partners
ChartMill
ChartMill
·
८ घण्टा पहिले
S&P 500 After-Hours Gainers for Nov. 17, 2026
Fox Business
Fox Business
·
१० घण्टा पहिले
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
Traders Union
Traders Union
·
४ घण्टा पहिले
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
About Balaxi Pharmaceuticals Ltd
CEO-
Employees५००
Founded१९४२
Headquarters-
SectorHealth Care
Industry-
Last report
२०२६ नोभेम्बर १२
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
८०.५४ करोड / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
७२.५४ करोड
७०.७१ करोड
८०.६८ करोड
८०.५४ करोड
Cost of goods sold
४१.७४ करोड
४१.४९ करोड
४३.१७ करोड
४२.५० करोड
Cost of revenue
४१.७४ करोड
४१.४९ करोड
४३.१७ करोड
४२.५० करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२७.७२ करोड
२९.१० करोड
३२.८५ करोड
३३.७५ करोड
Operating expense
२८.२८ करोड
२९.७५ करोड
३३.६९ करोड
३५.१७ करोड
Total operating expenses
७०.०१ करोड
७१.२४ करोड
७६.८७ करोड
७७.६७ करोड
Operating income
२.५३ करोड
-५२.४९ लाख
३.८१ करोड
२.८७ करोड
Other non operating income
९.५७ लाख
१.८३ करोड
-९९.२२ लाख
१.०० हजार
EBT including unusual items
१.६१ करोड
१.४० करोड
२.०९ करोड
२.०२ करोड
EBT excluding unusual items
१.६१ करोड
१.३० करोड
२.०९ करोड
२.०२ करोड
Income tax expense
१.३० करोड
७८.९८ लाख
७९.१८ लाख
८६.५२ लाख
Effective tax rate
८१.०५%
५६.३१%
३७.९०%
४२.९३%
Other operating expenses
-
-
-
-
Net income
३०.५० लाख
६१.२८ लाख
१.३० करोड
१.१५ करोड
Net profit margin
०.४२%
०.८७%
१.६१%
१.४३%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-१.०२ करोड
-९८.९९ लाख
-७३.२६ लाख
-८५.५५ लाख
Net interest expenses
-१.०२ करोड
-९८.९९ लाख
-७३.२६ लाख
-८५.५५ लाख
Depreciation and amortization charges
५५.९५ लाख
६४.६५ लाख
८४.८५ लाख
१.४२ करोड
EBITDA
२.९६ करोड
-३.२९ लाख
४.३१ करोड
४.०१ करोड
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू